FR2646605B1 - Activateur de neurones endommages, servant a la prevention et au traitement de maladies - Google Patents
Activateur de neurones endommages, servant a la prevention et au traitement de maladiesInfo
- Publication number
- FR2646605B1 FR2646605B1 FR898915798A FR8915798A FR2646605B1 FR 2646605 B1 FR2646605 B1 FR 2646605B1 FR 898915798 A FR898915798 A FR 898915798A FR 8915798 A FR8915798 A FR 8915798A FR 2646605 B1 FR2646605 B1 FR 2646605B1
- Authority
- FR
- France
- Prior art keywords
- activator
- prevention
- treatment
- diseases
- damaged
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Rheumatology (AREA)
- Ophthalmology & Optometry (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Cardiology (AREA)
- Microbiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1114852A JPH02292226A (ja) | 1989-05-08 | 1989-05-08 | 障害された神経細胞賦活予防治療剤 |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2646605A1 FR2646605A1 (fr) | 1990-11-09 |
FR2646605B1 true FR2646605B1 (fr) | 1992-08-07 |
Family
ID=14648320
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR898915798A Expired - Lifetime FR2646605B1 (fr) | 1989-05-08 | 1989-11-30 | Activateur de neurones endommages, servant a la prevention et au traitement de maladies |
Country Status (4)
Country | Link |
---|---|
JP (1) | JPH02292226A (fr) |
DE (2) | DE3943649C2 (fr) |
FR (1) | FR2646605B1 (fr) |
GB (1) | GB2231263A (fr) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007509982A (ja) | 2003-10-29 | 2007-04-19 | アルタス ファーマシューティカルズ インコーポレイテッド | 血漿コレシストキニン(cck)濃度を制御するための非膵臓プロテアーゼおよび痛みを処置するための非膵臓プロテアーゼ |
GB2450747A (en) * | 2007-07-06 | 2009-01-07 | Univ Sheffield | Treatment of sensorineural hearing loss |
CN109295041A (zh) * | 2018-10-10 | 2019-02-01 | 宁波希诺亚海洋生物科技有限公司 | 具有舍雷肽酶活性的多肽及其制备方法 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1064581A (en) * | 1964-04-06 | 1967-04-05 | Rorer Inc William H | Preparations containing an antitussive and an enzyme |
FR5218M (fr) * | 1965-06-18 | 1967-07-03 | ||
DE1955844A1 (de) * | 1969-11-06 | 1971-05-19 | Blendax Werke Schneider Co | Mittel zur Behandlung von Entzuendungen |
US3860702A (en) * | 1972-07-11 | 1975-01-14 | Schuyler Dev Corp | Anti-inflammatory compositions |
JPS57128634A (en) * | 1981-02-03 | 1982-08-10 | Eisai Co Ltd | Elastase-containing compound increasing absorption |
JPS5826822A (ja) * | 1981-08-10 | 1983-02-17 | Kaken Pharmaceut Co Ltd | 慢性腎炎治療剤 |
JPS58189122A (ja) * | 1982-04-30 | 1983-11-04 | Kaken Pharmaceut Co Ltd | 高脂血症予防治療剤 |
WO1984002846A1 (fr) * | 1983-01-21 | 1984-08-02 | Advanced Drug Tech | Onguent enzymatique |
JPS59225122A (ja) * | 1983-05-23 | 1984-12-18 | Kaken Pharmaceut Co Ltd | 悪液質治療改善剤 |
JPS608227A (ja) * | 1983-06-28 | 1985-01-17 | Kaken Pharmaceut Co Ltd | 抗アレルギ−増強剤 |
US4844897A (en) * | 1985-09-13 | 1989-07-04 | Hiroshi Maeda | Anti-tumor protease preparations |
JPS62215533A (ja) * | 1986-03-17 | 1987-09-22 | Shigemi Fujisaki | 膠原病又は関節リウマチの予防治療剤 |
EP0252004A1 (fr) * | 1986-06-26 | 1988-01-07 | Ciba-Geigy Ag | Compositions pharmaceutiques pour l'application parentérale |
JPS63295515A (ja) * | 1987-05-26 | 1988-12-01 | Kao Corp | 腸溶性抗血液凝固・血栓溶解製剤 |
CH680285A5 (fr) * | 1987-10-02 | 1992-07-31 | Ferag Ag |
-
1989
- 1989-05-08 JP JP1114852A patent/JPH02292226A/ja active Granted
- 1989-11-30 FR FR898915798A patent/FR2646605B1/fr not_active Expired - Lifetime
- 1989-12-14 DE DE3943649A patent/DE3943649C2/de not_active Expired - Fee Related
- 1989-12-14 DE DE3941324A patent/DE3941324A1/de active Granted
- 1989-12-21 GB GB8928811A patent/GB2231263A/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
DE3943649C2 (fr) | 1992-10-29 |
GB8928811D0 (en) | 1990-02-28 |
GB2231263A (en) | 1990-11-14 |
JPH02292226A (ja) | 1990-12-03 |
DE3941324C2 (fr) | 1992-06-25 |
DE3941324A1 (de) | 1990-11-15 |
FR2646605A1 (fr) | 1990-11-09 |
JPH0577655B2 (fr) | 1993-10-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EE9900481A (et) | Väikesed molekulid, mida kasutatakse põletikuliste haiguste raviks | |
FI964681A0 (fi) | Ihmisperäiset Lactobacillus-kannat, niitä sisältävät valmisteet ja niiden käytöt | |
ES2164842T3 (es) | Procedimiento para la preparacion de composiciones de microcapsulas. | |
HUP9801240A2 (en) | Oral compositions | |
TR199901174T2 (xx) | Yeni heterosiklilmetil-ikameli pirazol t�revleri. | |
BR9814743A (pt) | Tablete de detergente | |
CY1108610T1 (el) | Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες | |
FI980862A0 (fi) | Kiraalisia metyylifenyylioksatsolidinoneja | |
DE69709407D1 (de) | Zytotoxischer aminozucker und verwandte zuckerderivate von indolopyrrolocarbazolen | |
NO972391L (no) | 2-substituerte 1,2,5-tiadiazolidin-3-on 1,1-dioksider og preparater og metoder for anvendelse derav | |
NO914217L (no) | Sakkarinderivater nyttige som proteolytiske enzyminhibitorer og fremstilling derav | |
DE69636285D1 (de) | ISOLIERTES FrpB NUKLEINSÄUREMOLEKÜL UND ENTSPRECHENDE IMPFSTOFF | |
ATE203519T1 (de) | Chinolinderivate als antimalariamittel | |
BR9812222A (pt) | Preparação farmacêutica separada de complexo de protrombina, preparação diagnóstica, e, utilização de uma preparação | |
WO2003031585A3 (fr) | Molecules d'acide nucleique codant une serine protease transmembranaire 25, polypeptides codes et procedes connexes | |
NO980296D0 (no) | Forbedrede terapeutiske midler | |
FR2646605B1 (fr) | Activateur de neurones endommages, servant a la prevention et au traitement de maladies | |
PT1150703E (pt) | Terapia de esclerose multipla com chaperonina 10 e beta-interferao | |
NO180642C (no) | Alkalipullulanase og renisolert kultur av Bacillus sp. mikroorganisme som produserer denne | |
EA199700243A1 (ru) | Производное аминотетралина для лечения сердечно-сосудистых заболеваний | |
PT89742A (pt) | Processo de preparacao de 24r-cimnol e de suas composicoes farmaceuticas | |
ATE82124T1 (de) | Anwendung von n-(2-(diaethylamino)aethyl>-2-methoxy-4((1-h-4,5ihydro-2-imidazolyl)amino>-5- chlorobenzamid als anxiolytisches und antipsychotisches mittel. | |
ATE80143T1 (de) | Isomere formyl-trimethylbicyclo(2,2,2)oct-7-ene. | |
DE69614552D1 (de) | MODIFIZIERTE ALPHA-D-GLCP-(1,2)-ALPHA-D-Glcp-(1,3)-ALPHA-D-Glcp-ANALOGE | |
DK0642574T3 (da) | Detergentsammensætninger |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |